Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Modified FBXW7 circular RNA and application thereof in tumor drugs and new crown vaccines

A modified and cyclic technology, applied to the modified version of FBXW7 circular RNA and its application in tumor drugs and new crown vaccines, can solve the problem of high productivity, achieve high expression activity, easy preservation, and adaptability strong effect

Active Publication Date: 2021-03-30
楷拓生物科技(苏州)有限公司 +2
View PDF15 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example circRNAs undergo rolling circle amplification in an IRES-independent manner, resulting in 100-fold higher productivity than linear transcripts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modified FBXW7 circular RNA and application thereof in tumor drugs and new crown vaccines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0011] Customization of linear DNA templates: Firstly, the biological company ordered by DNA synthesis has complementary double-stranded DNA whose template sequences are SEQ ID NO.LD1 and SEQ ID NO.LD2. Both templates include the T7 promoter and the transformation of FBXW7 circular RNA The corresponding DNA sequence of the body RNA, and the corresponding DNA sequence of the RNA of the new coronavirus spike protein and guide protein inserted at the 287-288 position, the RNA sequence is SEQ ID NO.LR3, which is the D614G mutation, and at the 287-288 position The corresponding DNA sequence of p53 protein RNA was inserted respectively, and the RNA sequence was SEQ ID NO.LR4.

[0012] Using linear DNA as the template for amplification, the Invitrogen™ T7 RNA Polymerase Kit (Cat. No.: 18033019) from Thermo Fisher Scientific was used to amplify the RNA. The remaining template was degraded with DNase. The RNA product was purified and then circularized. The RNA Circularization Kit produ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a circular RNA modified body obtained by modifying a large number of artificial sequences on the basis of a natural FBXW7 circular RNA, the modified body having excellent translation and translation termination effects, and being capable of expressing the protein in vivo after an appropriate protein-encoding RNA sequence is inserted into the insertion site of the modified body. Different proteins can have different effects, so that the modified FBXW7 circular RNA can be used for preparing tumor treatment medicines and new crown vaccines.

Description

technical field [0001] The invention belongs to the field of biotechnology applications, and in particular relates to a modified form of FBXW7 circular RNA, a modified circular RNA modified by an artificial sequence, which has excellent translation and translation termination as a protein-coding RNA sequence Afterwards, the protein can be expressed in vivo, and different proteins can have different effects, which can be used to prepare tumor therapeutic drugs and also to prepare new crown vaccines. Background technique [0002] Vaccines are autoimmune preparations made by artificially attenuating, inactivating or using transgenic methods to prevent infectious diseases from pathogenic microorganisms and their metabolites. Vaccination is an effective way to prevent infectious diseases. Vaccines boost immunity and make an individual resistant to pathogen infection. Vaccines may contain live attenuated pathogens (usually viruses), inactivated whole pathogens, toxoids (inactiva...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113A61K48/00A61K39/00A61K39/215A61P35/00
CPCC12N15/1135C12N15/1131A61K48/00A61K39/001151A61K39/12A61P35/00C12N2310/532A61K2039/53C12N2770/20034Y02A50/30
Inventor 何越峰谭婧文周倩尹锦瑶孙明军毛一竹
Owner 楷拓生物科技(苏州)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com